ScoreWhy is Swedish Orphan Biovitrum AB ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 13.10%
2
With a growth in Net Profit of 33.29%, the company declared Outstanding results in Dec 25
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at SEK 8,564 MM
- NET PROFIT(HY) Higher at SEK 5,752.82 MM
- DEBT-EQUITY RATIO (HY) Lowest at 27.72 %
3
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
4
Market Beating performance in long term as well as near term
- Along with generating 33.08% returns in the last 1 year, the stock has outperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Swedish Orphan Biovitrum AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Swedish Orphan Biovitrum AB for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Swedish Orphan Biovitrum AB
33.08%
73.87
30.30%
OMX Stockholm 30
10.97%
0.59
18.59%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.10%
EBIT Growth (5y)
12.54%
EBIT to Interest (avg)
6.87
Debt to EBITDA (avg)
1.73
Net Debt to Equity (avg)
0.33
Sales to Capital Employed (avg)
0.47
Tax Ratio
12.54%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.02%
ROE (avg)
10.77%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.75
EV to EBIT
18.51
EV to EBITDA
11.77
EV to Capital Employed
2.36
EV to Sales
4.42
PEG Ratio
0.23
Dividend Yield
NA
ROCE (Latest)
12.73%
ROE (Latest)
11.90%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend20What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK 8,564 MM
NET PROFIT(HY)
Higher at SEK 5,752.82 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 27.72 %
RAW MATERIAL COST(Y)
Fallen by -8.35% (YoY
CASH AND EQV(HY)
Highest at SEK 2,080 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 3.43 times
NET SALES(Q)
Highest at SEK 7,821 MM
PRE-TAX PROFIT(Q)
At SEK 2,316 MM has Grown at 62.87%
EPS(Q)
Highest at SEK 5.34
-2What is not working for the Company
ROCE(HY)
Lowest at 1.23%
Here's what is working for Swedish Orphan Biovitrum AB
Net Profit
At SEK 5,752.82 MM has Grown at 99.64%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (SEK MM)
Operating Cash Flow
Highest at SEK 8,564 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Net Profit
Higher at SEK 5,752.82 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (SEK MM)
Debt-Equity Ratio
Lowest at 27.72 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Sales
Highest at SEK 7,821 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (SEK MM)
Pre-Tax Profit
At SEK 2,316 MM has Grown at 62.87%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
EPS
Highest at SEK 5.34
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (SEK)
Cash and Eqv
Highest at SEK 2,080 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 3.43 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -8.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
